Clinical and Translational Research
Copyright ©The Author(s) 2020.
World J Gastroenterol. Aug 7, 2020; 26(29): 4288-4301
Published online Aug 7, 2020. doi: 10.3748/wjg.v26.i29.4288
Table 3 Baseline characteristics of hepatitis B virus-associated acute-on-chronic liver failure patients enrolled in Study 2, n (%)
CharacteristicNutritional supportNone-nutritional supportP value
n234207
Age (yr)46.7 ± 10.847.5 ± 11.60.454
Male202 (86.3)172 (83.9)0.345
HBeAg positive98 (41.9)96 (46.4)0.342
HBV-DNA (log10 IU/mL)6.14 (1.85, 8.13)6.54 (1.53, 8.71)0.097
PLT (109/L)120.2 ± 49.1112.6 ± 52.60.117
ALT (IU/L)680 (421, 1191)652 (447, 1352)0.243
AST (IU/L)592 (313, 980)613 (320, 1014)0.381
ALB (g/L)33.6 ± 4.934.1 ± 5.20.299
TBIL (µmol/L)274.1 (166.1, 588.7)291.5 (162.5, 604.3)0.227
PTA (%)34 (14, 40)32 (11, 40)0.135
INR2.46 ± 0.182.49 ± 0.210.107
BUN (mmol/L)6.1 (3.1, 8.7)6.4 (3.2, 9.2)0.295
Cr (μmol/L)73 (66, 104)76 (59, 98)0.530
SBP124 (53.0)106 (51.2)0.708
Hepatic encephalopathy97 (41.5)82 (39.6)0.695
Hepatorenal syndrome24 (10.3)19 (9.2)0.703
MELD scores25.4 ± 4.826.1 ± 5.20.142
Artificial extracorporeal liver support141 (60.3)124 (59.9)0.940